June 29, 2012 at 10:31 AM EDT
China Earmarks $11.8 Billion for Drug Innovation in 2016-2020 Five-Year Plan
China plans to spend 75 Billion RMB ($11.8 billion) to increase biopharma innovation in its 13th Five-Year Plan, which covers the period 2016-2020. That is almost double the 40 billion RMB ($6.3 billion) it will spend in the current period, the 12th Five-Year Plan for 2011-2015, bringing its ten-year total to over $18 billion. The news was delivered by Chen Zhu, China’s Minister of Health, who was speaking recently at the BioChina Convention. More details..... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here